JSPR Research and Charts

JSPR - Jasper Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-13 (Delayed quote data 2025-01-06)

Last 20.87	Change ⇑ +1.60 (+8.30%)	Volume 437,201
	Open 19.82	High 21.06	Low 19.64

8EMA (Daily) 21.00	40EMA (Daily) 21.49	50EMA (Daily) 21.41	STO (Daily) 38.595	MACD Hist (Daily) -0.377
8EMA (Weekly) 21.036	40EMA (Weekly) 19.58	50EMA (Weekly) 18.64	STO (Weekly) 55.783	MACD Hist (Weekly) -0.388


Company Profile
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.